Olema Pharmaceuticals, Inc. Common Stock
OLMA
OLMA: Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250.
moreShow OLMA Financials
Recent trades of OLMA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by OLMA's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Tetrahydro-1h-pyrido [3,4-b]indole anti-estrogenic drugs Jun. 13, 2023
-
Patent Title: Tetrahydro-1h-pyrido [3,4-b]indole anti-estrogenic drugs Jan. 25, 2022
-
Patent Title: Tetrahydro-1h-pyrido[3,4-b]indole anti-estrogenic drugs May. 21, 2019
-
Patent Title: Benzopyran compounds, compositions and uses thereof Apr. 28, 2015
-
Patent Title: Substituted triphenyl butenes Nov. 22, 2011
Federal grants, loans, and purchases
Followers on OLMA's company Twitter account
Number of mentions of OLMA in WallStreetBets Daily Discussion
Recent insights relating to OLMA
Recent picks made for OLMA stock on CNBC
ETFs with the largest estimated holdings in OLMA
Flights by private jets registered to OLMA